TransMedics Group, Inc. Gross Profit
TransMedics Group, Inc. (TMDX) reported Gross Profit of $113.20 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement
us-gaap:GrossProfit · last filed 2026-08-04
- TransMedics Group, Inc. gross profit for the quarter ending 2026-06-30 was $113.20M, a 17.20% increase year-over-year.
- TransMedics Group, Inc. gross profit for the quarter ending 2026-03-31 was $101.16M, a 14.66% increase year-over-year.
- TransMedics Group, Inc. gross profit for the quarter ending 2025-12-31 was $93.41M, a 29.72% increase year-over-year.
- TransMedics Group, Inc. gross profit for the quarter ending 2025-09-30 was $84.58M, a 39.00% increase year-over-year.
- TransMedics Group, Inc. gross profit for fiscal 2025 was $362.81M, a 38.43% increase from fiscal 2024.
- TransMedics Group, Inc. gross profit for fiscal 2024 was $262.08M, a 70.08% increase from fiscal 2023.
- TransMedics Group, Inc. gross profit for fiscal 2023 was $154.09M, a 136.08% increase from fiscal 2022.
- TransMedics Group, Inc. gross profit for fiscal 2022 was $65.27M, a 208.48% increase from fiscal 2021.
| Period end | Gross Profit 3 month | Gross Profit 6 month | Gross Profit 9 month | Gross Profit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $113.20M 10-Q · filed 2026-08-04 | $214.36M 10-Q · filed 2026-08-04 | $307.77M derived: sum of 3 quarters · filed 2026-08-04 | $392.35M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $101.16M 10-Q · filed 2026-05-05 | $194.57M derived: sum of 2 quarters · filed 2026-05-05 | $279.15M derived: sum of 3 quarters · filed 2026-05-05 | $375.74M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $93.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $177.99M derived: sum of 2 quarters · filed 2026-02-24 | $274.58M derived: sum of 3 quarters · filed 2026-08-04 | $362.81M 10-K · filed 2026-02-24 |
| 2025-09-30 | $84.58M 10-Q · filed 2025-10-29 | $181.16M derived: sum of 2 quarters · filed 2026-08-04 | $269.39M 10-Q · filed 2025-10-29 | $341.40M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $96.59M 10-Q · filed 2026-08-04 | $184.82M 10-Q · filed 2026-08-04 | $256.83M derived: sum of 3 quarters · filed 2026-08-04 | $317.68M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $88.23M 10-Q · filed 2026-05-05 | $160.24M derived: sum of 2 quarters · filed 2026-05-05 | $221.09M derived: sum of 3 quarters · filed 2026-05-05 | $290.35M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $72.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $132.86M derived: sum of 2 quarters · filed 2026-02-24 | $202.12M derived: sum of 3 quarters · filed 2026-02-24 | $262.08M 10-K · filed 2026-02-24 |
| 2024-09-30 | $60.84M 10-Q · filed 2025-10-29 | $130.11M derived: sum of 2 quarters · filed 2025-10-29 | $190.07M 10-Q · filed 2025-10-29 | $237.99M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $69.26M 10-Q · filed 2025-07-30 | $129.22M 10-Q · filed 2025-07-30 | $177.15M derived: sum of 3 quarters · filed 2026-02-24 | $217.81M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $59.96M 10-Q · filed 2025-05-08 | $107.89M derived: sum of 2 quarters · filed 2026-02-24 | $148.55M derived: sum of 3 quarters · filed 2026-02-24 | $185.29M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $47.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $88.59M derived: sum of 2 quarters · filed 2026-02-24 | $125.33M derived: sum of 3 quarters · filed 2026-02-24 | $154.09M 10-K · filed 2026-02-24 |
| 2023-09-30 | $40.66M 10-Q · filed 2024-10-29 | $77.40M derived: sum of 2 quarters · filed 2024-10-29 | $106.17M 10-Q · filed 2024-10-29 | $126.87M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $36.74M 10-Q · filed 2024-08-01 | $65.51M 10-Q · filed 2024-08-01 | $86.21M derived: sum of 3 quarters · filed 2025-02-27 | $104.33M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $28.77M 10-Q · filed 2024-05-02 | $49.47M derived: sum of 2 quarters · filed 2025-02-27 | $67.58M derived: sum of 3 quarters · filed 2025-02-27 | $81.93M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $20.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $38.82M derived: sum of 2 quarters · filed 2025-02-27 | $53.17M derived: sum of 3 quarters · filed 2025-02-27 | $65.27M 10-K · filed 2025-02-27 |
| 2022-09-30 | $18.11M 10-Q · filed 2023-11-08 | $32.47M derived: sum of 2 quarters · filed 2023-11-08 | $44.57M 10-Q · filed 2023-11-08 | $51.55M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $14.35M 10-Q · filed 2023-08-04 | $26.45M 10-Q · filed 2023-08-04 | $33.44M derived: sum of 3 quarters · filed 2024-02-27 | $37.21M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $12.10M 10-Q · filed 2023-05-04 | $19.09M derived: sum of 2 quarters · filed 2024-02-27 | $22.86M derived: sum of 3 quarters · filed 2024-02-27 | $28.45M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $6.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $10.76M derived: sum of 2 quarters · filed 2024-02-27 | $16.35M derived: sum of 3 quarters · filed 2024-02-27 | $21.16M 10-K · filed 2024-02-27 |
| 2021-09-30 | $3.77M 10-Q · filed 2022-11-04 | $9.36M derived: sum of 2 quarters · filed 2022-11-04 | $14.17M 10-Q · filed 2022-11-04 | $19.00M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $5.59M 10-Q · filed 2022-08-03 | $10.40M 10-Q · filed 2022-08-03 | $15.23M derived: sum of 3 quarters · filed 2022-08-03 | $20.27M derived: sum of 4 quarters · filed 2022-08-03 |
| 2021-03-31 | $4.81M 10-Q · filed 2022-05-05 | $9.64M derived: sum of 2 quarters · filed 2022-05-05 | $14.68M derived: sum of 3 quarters · filed 2022-05-05 | $16.59M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $4.83M 10-K · filed 2021-03-11 | $9.87M derived: sum of 2 quarters · filed 2021-11-09 | $11.78M derived: sum of 3 quarters · filed 2021-11-09 | $16.64M 10-K · filed 2021-03-11 |
| 2020-09-30 | $5.04M 10-Q · filed 2021-11-09 | $6.95M derived: sum of 2 quarters · filed 2021-11-09 | $11.81M 10-Q · filed 2021-11-09 | $15.55M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $1.91M 10-Q · filed 2021-08-06 | $6.77M 10-Q · filed 2021-08-06 | $10.51M derived: sum of 3 quarters · filed 2021-08-06 | $14.73M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $4.86M 10-K · filed 2021-03-11 | $8.60M derived: sum of 2 quarters · filed 2021-05-07 | $12.82M derived: sum of 3 quarters · filed 2021-05-07 | $16.15M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-28 | $3.74M 10-K · filed 2021-03-11 | $7.96M derived: sum of 2 quarters · filed 2021-03-11 | $11.29M derived: sum of 3 quarters · filed 2021-03-11 | $13.86M 10-K · filed 2021-03-11 |
| 2019-09-28 | $4.22M 10-K · filed 2021-03-11 | $7.55M derived: sum of 2 quarters · filed 2021-03-11 | $10.12M 10-Q · filed 2019-11-08 | $11.62M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-29 | $3.33M 10-K · filed 2021-03-11 | $5.91M 10-Q · filed 2020-08-07 | $7.41M derived: sum of 3 quarters · filed 2021-03-11 | $9.54M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-30 | $2.57M 10-K · filed 2021-03-11 | $4.07M derived: sum of 2 quarters · filed 2021-03-11 | $6.20M derived: sum of 3 quarters · filed 2021-03-11 | $7.38M derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-29 | $1.50M 10-K · filed 2020-03-17 | $3.63M derived: sum of 2 quarters · filed 2020-03-17 | $4.81M derived: sum of 3 quarters · filed 2020-03-17 | $5.73M 10-K · filed 2020-03-17 |
| 2018-09-29 | $2.13M 10-K · filed 2020-03-17 | $3.31M derived: sum of 2 quarters · filed 2020-03-17 | $4.24M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $1.18M 10-K · filed 2020-03-17 | $2.10M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $924.00K 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |